Ori Biotech focuses on the manufacturing of cell and gene therapies. The company provides tools and solutions to assist scientists in improving the efficiency and effectiveness of therapy development.
The Cell and Gene Therapy Catapult is an independent innovation and technology organisation dedicated to advancing the cell and gene therapy industry through powerful collaborations.
Bloomsbury Genetic Therapies is a clinical-stage biotechnology company dedicated to delivering potentially curative gene therapy treatments for patients suffering from rare neurological and metabolic diseases.
Company Details
Ori Biotech is operated by Oribiotech Ltd and is a Active company incorporated on 2 September 2015 with the registered office located in London, Greater London. Oribiotech Ltd was registered 10 years ago.